Photo from academic.microsoft.com
AC and CMP are supported by the UK National Institute for Health Research (NIHR) Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and King’s College London;… Click to show full abstract
AC and CMP are supported by the UK National Institute for Health Research (NIHR) Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and King’s College London; and by the UK Medical Research Council, Grants MR/ L014815/1 and MR/J002739/1. CMP has received research funding from pharmaceutical companies interested in the development of new antidepressants, such as Johnson & Johnson and Eleusis, but the work described in this paper is not related to this funding. AC does not have any conflict of interest.
Journal Title: Neuropsychopharmacology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!